Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study
Yiyang Yan, Tao Wang, Shaobo Fang, Dan Li. Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study. // Cancer Imaging. – 2026. – DOI: 10.1186/s40644-026-01159-w. – URL: https://doi.org/10.1186/s40644-026-01159-w
Yiyang Yan, Tao Wang, Shaobo Fang, & Dan Li (2026). Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study. Cancer Imaging. https://doi.org/10.1186/s40644-026-01159-w
Yiyang Yan, et al. “Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study.” Cancer Imaging, 2026. doi:10.1186/s40644-026-01159-w.
@article{Yan2026,
title = {Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study},
author = {Yan, Yiyang and Wang, Tao and Fang, Shaobo and Li, Dan},
journal = {Cancer Imaging},
year = {2026},
doi = {10.1186/s40644-026-01159-w},
url = {https://doi.org/10.1186/s40644-026-01159-w}
}